Case number 1:22-cv-01391
Alcon Inc. et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 12, 2022 | 8 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 12/12/2022) (2) |
| Dec 8, 2022 | 7 | NOTICE of Dismissal by Alcon Inc., Alcon Laboratories, Inc. (Joyce, Alexandra) (Entered: 12/08/2022) (1) |
| Oct 24, 2022 | 1 | Complaint* (1) |
| Oct 24, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 10/24/2022) (3) |
| Oct 24, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: May 19, 2032. (mkr) (Entered: 10/24/2022) (1) |
| Oct 24, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,154 ;9,533,053. (mkr) (Entered: 10/24/2022) (1) |
| Oct 24, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alcon Inc. for Alcon Inc. and Alcon Laboratories, Inc. filed by Alcon Inc. and Alcon Laboratories, Inc. (mkr) (Entered: 10/24/2022) (1) |
| Oct 24, 2022 | 6 | Summons Issued as to Aurobindo Pharma Ltd. on 10/24/2022 and Aurobindo Pharma USA, Inc. on 10/24/2022. (Attachments: # 1 Summons Issued)(mkr) (Entered: 10/24/2022) (Main Document) (2) |
| Oct 24, 2022 | 6 | Summons Issued as to Aurobindo Pharma Ltd. on 10/24/2022 and Aurobindo Pharma USA, Inc. on 10/24/2022. (Attachments: # 1 Summons Issued)(mkr) (Entered: 10/24/2022) (Summons Issued) (2) |
